SAB Biotherapeutics, Inc. (SABS)
3.60
+0.03
(+0.84%)
USD |
NASDAQ |
May 29, 16:00
3.60
0.00 (0.00%)
Pre-Market: 20:00
SAB Biotherapeutics Total Liabilities (Quarterly) : 21.22M for March 31, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 1.669B |
| Oncolytics Biotech, Inc. | 13.29M |
| Sangamo Therapeutics, Inc. | 78.92M |
| Sarepta Therapeutics, Inc. | 1.674B |
| Anixa Biosciences, Inc. | 1.387M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 248.47M |
| Shareholders Equity (Quarterly) | 227.25M |
| Debt to Equity Ratio | 0.0272 |
| Current Ratio | 11.45 |
| Net Debt Paydown Yield | -0.10% |